(Q33233438)

24 July 2017

Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications (English)

1 reference

24 July 2017

tobacco mosaic virus

1 reference

Kenneth E Palmer

8

0 references

author name string

Mark L Smith

1

1 reference

24 July 2017

John A Lindbo

2

1 reference

24 July 2017

Stephan Dillard-Telm

3

1 reference

24 July 2017

Paul M Brosio

4

1 reference

24 July 2017

Amanda B Lasnik

5

1 reference

24 July 2017

Alison A McCormick

6

1 reference

24 July 2017

Long V Nguyen

7

1 reference

24 July 2017

language of work or name

English

0 references

publication date

8 February 2006

1 reference

24 July 2017

1 reference

24 July 2017

348

1 reference

24 July 2017

2

1 reference

24 July 2017

475-488

1 reference

The influence of antigen organization on B cell responsiveness

24 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Isolation and properties of streptavidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Display of epitopes on the surface of tobacco mosaic virus: impact of charge and isoelectric point of the epitope on virus-host interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Chemical conjugation of heterologous proteins on the surface of Cowpea mosaic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Mechanism of dye response and interference in the Bradford protein assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Mechanism studies of coomassie blue and silver staining of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

TMV coat protein synthesis in vivo: analysis of the N-terminal acetylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Production of a soluble and functional recombinant streptavidin in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Iminobiotin affinity columns and their application to retrieval of streptavidin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Insertion of foreign epitopes in HBcAg: how to make the chimeric particle assemble

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Maintenance of coat protein N-terminal net charge and not primary sequence is essential for zucchini yellow mosaic virus systemic infectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Bacterial expression and refolding of single-chain Fv fragments with C-terminal cysteines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Native display of complete foreign protein domains on the surface of hepatitis B virus capsids.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Control of dendritic cell cross-presentation by the major histocompatibility complex class I cytoplasmic domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Comparative immunogenicities of tobacco mosaic virus, protein subunits, and reaggregated protein subunits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Expression of biotin-binding proteins, avidin and streptavidin, in plant tissues using plant vacuolar targeting sequences.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Synthetic malaria peptide vaccine elicits high levels of antibodies in vaccinees of defined HLA genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Affinity purification of streptavidin using tobacco mosaic virus particles as purification tags

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Cross-neutralization of cutaneous and mucosal Papillomavirus types with anti-sera to the amino terminus of L2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Making an ally from an enemy: plant virology and the new agriculture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Cowpea mosaic virus-based chimaeras. Effects of inserted peptides on the phenotype, host range, and transmissibility of the modified viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

A streptavidin-protein A chimera that allows one-step production of a variety of specific antibody conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Streptavidin-containing chimeric proteins: design and production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Assembly and movement of a plant virus carrying a green fluorescent protein overcoat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Dual-surface modification of the tobacco mosaic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Heterologous sequences greatly affect foreign gene expression in tobacco mosaic virus-based vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Production of a functional single chain antibody attached to the surface of a plant virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector*1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2005.12.039

10.1016/J.VIROL.2005.12.039

7 January 2021

Identifiers

DOI

1 reference

24 July 2017

1 reference